Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05563415 · ClinicalTrials.gov registry record · NA

AWV Practice Redesign Toolkit (Tailored Intervention)

A NA study of Preventive Health Services, sponsored by University of California, Los Angeles.

Active
Registry status
NA
Development phase
13,321
Enrollment target
1
Study location

NCT05563415: Active NA study of Preventive Health Services, sponsored by University of California, Los Angeles.

NCT05563415 is a NA study of Preventive Health Services that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 13,321 participants, below the 39,380-participant average among 7 other Preventive Health Services trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05563415, a NA study of Preventive Health Services, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
13,321 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to improve the use of preventive health services by implementing the AWV Practice Redesign Toolkit to stimulate AWV visit use in diverse practices across the United States. This is a stepped wedge cluster randomized controlled trial. The intervention will be implemented in a total of 16 small-to-mid-size primary care practices (at the practice level) with clinicians and staff. Eight practices will participate in the main clinical trial, and 8 in a replication study. The main clinical trial (with community-based practices) and replication study (with Federally Qualified Health Center practices) will be conducted simultaneously. Electronic health record (EHR) data extractions will be used to collect outcomes in a population cohort of patients. Semi-structured interviews will be conducted with clinicians/staff and patients to assess intervention implementation. The investigators hypothesize that the toolkit implementation will increase AWV visit use and consequently, use of preventive health services.

Primary Outcome

% of eligible patients completing an AWV (CPT codes G0438 or G0439) or Initial Preventive Physical Examination (IPPE) (CPT code G0422) in the past 12 months

Conditions Studied

Interventions

  • BEHAVIORAL Medicare AWV Practice Redesign Toolkit

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 13,321 participants
Start Date 2023-05-15
Est. Completion 2026-09-30
Phase NA

What the registry record for NCT05563415 still lists

NCT05563415 is an interventional study that assigns participants to a tested intervention. Its 13,321 participants enrollment target places it among the larger protocols in the corpus, below the 39,380-participant average among 7 other Preventive Health Services trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Preventive Health Services appearing as the primary indexed condition, and to 1 intervention - of which Medicare AWV Practice Redesign Toolkit is the first listed.

NCT05563415 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05563415 about?

NCT05563415 is a clinical study titled "AWV Practice Redesign Toolkit (Tailored Intervention)". The goal of this study is to improve the use of preventive health services by implementing the AWV Practice Redesign Toolkit to stimulate AWV visit use in diverse practices across the United States. This is a stepped wedge cluster randomized controlled trial. The intervention will be implemented in ...

What is the current status of trial NCT05563415?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 13,321 participants. The study started on 2023-05-15. Estimated completion is 2026-09-30.

What conditions does trial NCT05563415 study?

This clinical trial studies the following conditions: Preventive Health Services.

What interventions are being tested in trial NCT05563415?

The interventions under investigation include: Medicare AWV Practice Redesign Toolkit (BEHAVIORAL).

Who is sponsoring clinical trial NCT05563415?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05563415 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Preventive Health Services

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05141396 · 13,400 participants · NA

    Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)

  • NCT05991453 · 13,000 participants · NA

    Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

  • NCT07177352 · 13,000 participants · Phase 3

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • NCT07028398 · 12,990 participants · NA

    CMSL Ambulatory Sensitive Condition Nudge Study 2

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05563415, the US trial registry maintained by the National Library of Medicine. NCT05563415 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.